Navigation Links
Team to study control of malaria-related parasite growth with $2.1-million NIH grant

Animal cells similar to those of humans contain a "control room," called the centrosome, which regulates cell replication. Disrupt this core hub and you kill cell division.

That is the simple idea behind a new five-year, $2.1-million National Institutes for Health grant recently awarded to the USF College of Public Health's Department of Global Health and the Florida Center for Drug Development and Innovation.

The National Institute of Allergy and Infectious Diseases-funded study may help identify new factors required for the growth of malaria-related parasites and lead to new therapies to combat malaria, a mosquito-borne tropical disease that exacts a huge toll on human health in developing countries.

The project began with a key discovery by Michael White, PhD, professor of global health at USF Health, and Elena Suvorova, PhD, a research assistant professor at the USF Center for Drug Development and Innovation (CDDI).

They showed that in malaria-related parasites known as Toxoplasma gondii the centrosome is more complex and very different from their human hosts. The parasite hub houses novel factors, including unusual protein kinases, or enzymes, that offer new targets for drug development.

Principal investigator White and co-principal investigator Suvorova will collaborate with newly hired CDDI medicinal chemist Jim Leahy, PhD, an expert in developing drugs against kinases in cancer, and University of Georgia cell biologist Boris Striepen, PhD, to study centrosome control of Toxoplasma growth.


Contact: Anne DeLotto Baier
University of South Florida (USF Health)

Page: 1

Related medicine news :

1. Practice makes perfect if you have a partners touch, according to new study
2. Study shows 1 in 5 women with ovarian cancer has inherited predisposition
3. Study could lead to liquid biopsy tests for bladder cancer
4. New study examines patterns of cancer screening in Appalachian women
5. Regenstrief, IU study: Half of hospitalized adults over 65 need surrogate decision-makers
6. Study: Possible new druggable target in Ewings Sarcoma
7. Miriam Hospital study links intimate partner violence and risk of HIV
8. Study reveals how ecstasy acts on the brain and hints at therapeutic uses
9. Study finds troubling relationship between drinking and PTSD symptoms in college students
10. China Laser Equipment Industry Production Capacity to Be 2.77 Times More by 2017 in a New Study at
11. Study questions anti-cancer mechanisms of drug tested in clinical trials
Post Your Comments:
Related Image:
Team to study control of malaria-related parasite growth with $2.1-million NIH grant
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology: